13:19:23 EDT Mon 21 Oct 2019
Enter Symbol
or Name
USA
CA



Login ID:
Password:
Save
GeneNews Ltd (2)
Symbol C : GEN
Shares Issued 158,261,234
Close 2019-03-29 C$ 0.17
Recent Sedar Documents

GeneNews to release 2018 results April 2

2019-03-29 11:12 ET - News Release

Mr. James Howard-Tripp reports

GENENEWS ANNOUNCES FOURTH QUARTER 2018 RESULTS AND YEAR END INVESTOR CALL

GeneNews Ltd. will release its fourth quarter 2018 results before markets open on Tuesday, April 2, 2019. GeneNews's chairman and chief executive officer, James R. Howard-Tripp, will host a conference call at 4:30 p.m. ET on April 3 to review the results and discuss business developments for the period.

Fourth quarter 2018 results conference call details

Date:  Tuesday, April 3, 2019

Time:  4:30 p.m. ET

Live call (participant):  877-407-8033, 201-689-8033

Playback phone numbers

Replay:  877-481-4010

PIN:  45694

Playback expiration date:  April 9, 2019

About GeneNews Ltd.

GeneNews is dedicated to developing and commercializing innovative solutions for early cancer detection. The company's mission is to provide advanced diagnostics that can help physicians identify cancer in their patients at the earliest-possible stage, when it is the most curable. In addition to building a pipeline of products for early cancer detection, GeneNews operates a CAP-accredited clinical reference lab based in Richmond, Va., that offers the ColonSentry test as well as licensed biomarker tests for lung, breast and prostate cancers.

We seek Safe Harbor.

© 2019 Canjex Publishing Ltd. All rights reserved.